Andrew Fein
Stock Analyst at HC Wainwright & Co.
(4.22)
# 485
Out of 5,005 analysts
597
Total ratings
48.99%
Success rate
16.17%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $400 → $500 | $453.07 | +10.36% | 17 | Sep 5, 2025 | |
| BIIB Biogen | Maintains: Buy | $187 → $194 | $159.88 | +21.34% | 22 | Aug 1, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $9.22 | +30.15% | 18 | Jul 29, 2025 | |
| KALV KalVista Pharmaceuticals | Reiterates: Buy | $27 | $11.85 | +127.85% | 16 | Jul 11, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $5.56 | +313.67% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $57.90 | +3.63% | 8 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $21.80 | +46.79% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $403.30 | +36.37% | 27 | Jun 23, 2025 | |
| INSM Insmed | Maintains: Buy | $90 → $120 | $157.16 | -23.64% | 15 | Jun 11, 2025 | |
| PEPG PepGen | Maintains: Buy | $14 → $8 | $5.13 | +55.95% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $3.49 | -42.69% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $22.43 | +56.04% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $9.92 | +41.13% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $25.56 | +36.93% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $3.19 | +338.87% | 16 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $27.28 | +174.93% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $68 | $47.00 | +44.68% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $3.32 | +201.20% | 10 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $13.06 | +190.96% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $16 | $13.42 | +19.23% | 20 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $15.94 | +56.84% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $15.42 | +107.52% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $7.15 | +319.58% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $12.90 | +24.03% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $9.61 | +149.74% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $3.99 | +200.75% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $65.78 | -42.23% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.54 | +214.96% | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $137.03 | +22.60% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $4.32 | +62.04% | 13 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $1.73 | +535.84% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.61 | +521.12% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $7.15 | +207.69% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $2 | $0.91 | +120.14% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $2.45 | +389.80% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $4.64 | +180.17% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $6.82 | +61.29% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $4.96 | +363.71% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $2.11 | +610.90% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $94.29 | -9.85% | 16 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $20.84 | +67.95% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $14.83 | +405.73% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $39.82 | +88.35% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $2.27 | +208.37% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $4.87 | +105.34% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $1.94 | +7,631.96% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $18.84 | +218.47% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $5.74 | +161.32% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $1.50 | +2,566.67% | 3 | Mar 16, 2022 |
United Therapeutics
Sep 5, 2025
Maintains: Buy
Price Target: $400 → $500
Current: $453.07
Upside: +10.36%
Biogen
Aug 1, 2025
Maintains: Buy
Price Target: $187 → $194
Current: $159.88
Upside: +21.34%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $9.22
Upside: +30.15%
KalVista Pharmaceuticals
Jul 11, 2025
Reiterates: Buy
Price Target: $27
Current: $11.85
Upside: +127.85%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $5.56
Upside: +313.67%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $57.90
Upside: +3.63%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $21.80
Upside: +46.79%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $403.30
Upside: +36.37%
Insmed
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $157.16
Upside: -23.64%
PepGen
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $5.13
Upside: +55.95%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $3.49
Upside: -42.69%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $22.43
Upside: +56.04%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $9.92
Upside: +41.13%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $25.56
Upside: +36.93%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $3.19
Upside: +338.87%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $27.28
Upside: +174.93%
May 12, 2025
Maintains: Buy
Price Target: $72 → $68
Current: $47.00
Upside: +44.68%
May 9, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $3.32
Upside: +201.20%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $13.06
Upside: +190.96%
May 9, 2025
Maintains: Buy
Price Target: $12 → $16
Current: $13.42
Upside: +19.23%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $15.94
Upside: +56.84%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $15.42
Upside: +107.52%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $7.15
Upside: +319.58%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $12.90
Upside: +24.03%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $9.61
Upside: +149.74%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $3.99
Upside: +200.75%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $65.78
Upside: -42.23%
Apr 28, 2025
Reiterates: Buy
Price Target: $8
Current: $2.54
Upside: +214.96%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $137.03
Upside: +22.60%
Apr 4, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $4.32
Upside: +62.04%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $1.73
Upside: +535.84%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $1.61
Upside: +521.12%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $7.15
Upside: +207.69%
Mar 17, 2025
Downgrades: Neutral
Price Target: $12 → $2
Current: $0.91
Upside: +120.14%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $2.45
Upside: +389.80%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $4.64
Upside: +180.17%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $6.82
Upside: +61.29%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $4.96
Upside: +363.71%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $2.11
Upside: +610.90%
Mar 3, 2025
Reiterates: Buy
Price Target: $85
Current: $94.29
Upside: -9.85%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $20.84
Upside: +67.95%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $14.83
Upside: +405.73%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $39.82
Upside: +88.35%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $2.27
Upside: +208.37%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $4.87
Upside: +105.34%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $1.94
Upside: +7,631.96%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $18.84
Upside: +218.47%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $5.74
Upside: +161.32%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $1.50
Upside: +2,566.67%